Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties

PLoS ONE(2020)10.1371/journal.pone.0227727Source: DataRank Database

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: goldTopics (45)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Marietta Tan ORCID,Ssu-Hsueh Tseng,Shiwen Peng ORCID,Ruey-Shyang Soong,Aliyah Algethami

Live enrichment

PubMed:31940398 PMC:PMC6961910

NCI NIH HHS

Grant: P30 CA006973

NCI NIH HHS

Grant: P50 CA228991

National Institutes of Health

Grant: P50CA098252

Ovarian Cancer Research Fund Alliance

Grant: 458972

National Institutes of Health

Grant: P30CA06973

American Heart Association-American Stroke Association

Grant: 14SDG18890049

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 5P50CA228991-02

SPORE in Ovarian Cancer

National Institutes of Health

Grant: 5P50CA098252-17

SPORE in Cervical Cancer

National Institutes of Health

Grant: 2P50CA098252-11

A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei

Allegheny Health Network

goldLicense: CC BY

Unpaywallhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0227727&type=printable

Europe_PMChttps://europepmc.org/articles/PMC6961910

Europe_PMChttps://europepmc.org/articles/PMC6961910?pdf=render

https://doi.org/10.1371/journal.pone.0227727

https://pubmed.ncbi.nlm.nih.gov/31940398

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsHumansMiceNeoplasmsBenzylidene CompoundsProteasome Endopeptidase ComplexIntracellular Signaling Peptides and ProteinsUbiquitinAntineoplastic AgentsXenograft Model Antitumor AssaysInhibitory Concentration 50Molecular StructureProtein BindingStructure-Activity RelationshipFemaleUbiquitinationUbiquitinated ProteinsProteasome Inhibitors

Keywords

Proteasome Endopeptidase ComplexScienceAntineoplastic AgentsBenzylidene CompoundsInhibitory Concentration 50MiceStructure-Activity RelationshipCell Line, TumorNeoplasmsAnimalsHumansMolecular StructureUbiquitinQRIntracellular Signaling Peptides and ProteinsUbiquitinationUbiquitinated ProteinsXenograft Model Antitumor AssaysMedicineFemaleProteasome InhibitorsResearch ArticleProtein Binding

Sustainable Development Goals

SDG 3: 3. Good health

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties

FAIR Checklist

Authors (13)

Funding (11 grants)

Open Access

Topics

Annotations (Europe PMC)